Detalles de la búsqueda
1.
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
N Engl J Med
; 380(8): 711-719, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30511879
2.
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
Cancer
; 125(6): 892-901, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30512189
3.
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Cancer
; 124(10): 2174-2183, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29533458
4.
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Lancet Oncol
; 18(11): 1523-1531, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055736
5.
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 17(12): 1643-1652, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27751847
6.
Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung.
Oncologist
; 21(2): 205-13, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26768483
7.
Probability of cancer in pulmonary nodules detected on first screening CT.
N Engl J Med
; 369(10): 910-9, 2013 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24004118
8.
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies.
J Transl Med
; 14: 83, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27036206
9.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Lancet Oncol
; 16(8): 897-907, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26156651
10.
Plasma pro-surfactant protein B and lung function decline in smokers.
Eur Respir J
; 45(4): 1037-45, 2015 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25614175
11.
Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer.
Curr Opin Oncol
; 27(2): 102-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25611026
12.
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.
Lancet Oncol
; 15(12): 1379-88, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439692
13.
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Nat Med
; 30(3): 716-729, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38351187
14.
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.
Int J Cancer
; 132(7): 1547-55, 2013 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22948899
15.
Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic.
Curr Oncol
; 29(5): 3171-3186, 2022 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621648
16.
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
J Thorac Oncol
; 17(3): 434-445, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800700
17.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial.
EClinicalMedicine
; 37: 100940, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34195574
18.
Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model.
Front Oncol
; 11: 761045, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804962
19.
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.
Cancer Med
; 10(9): 3045-3058, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811746
20.
A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model.
Crit Rev Oncol Hematol
; 148: 102896, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32087510